Metastatic Breast Cancer mHealth App to Promote Patient-Provider Communication: Protocol for a Usability and Satisfaction Study
Open Access
- 8 September 2025
- journal article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e66050
Abstract
Background: With the availability of more advanced and effective treatments, life expectancy has improved among patients with metastatic breast cancer (MBC), but this makes communication with their medical oncologist more complex. Some patients struggle to learn about their therapeutic options and to understand and articulate their preferences. Mobile health (mHealth) apps can enhance patient-provider communication, playing a crucial role in the diagnosis, treatment, quality of life, and outcomes for patients living with MBC. Our team developed an app called My MBC Journey to focus on the collection of important information for patients with MBC between clinical encounters. Objective: This study will evaluate the usability and satisfaction of My MBC Journey, a mobile app designed for MBC, to inform future modifications. Methods: This mixed methods study will assess patient use and satisfaction with the My MBC Journey app to inform future app modifications and identify the barriers and facilitators to the app’s use for enhancing patient-provider communication. We will recruit a prospective, cross-sectional convenience sample of 25 patients with MBC and a sample of 15 members of the care team (ie, caregivers, nurse navigators, and medical oncologists). Applying iterative, convergent mixed methods, we will conduct qualitative, semistructured interviews with the patients and care team members. We also will collect quantitative data on usability through app analytics and standardized questionnaires (ie, the Mobile Application Rating Scale, the Mobile Application Rating Scale user version, and the System Usability Scale). Qualitative interviews will be audio recorded and analyzed using NVivo software to identify mHealth implementation themes. Results: The study’s results will inform future app design modifications and gauge preliminary effect size in support of future evaluations of the app’s efficacy in improving patient-provider communication. Conclusions: Our long-term goal is to improve patient-provider communication by developing mHealth apps that empower patients to collect and share clinically relevant, patient-reported information in a timely manner. International Registered Report Identifier (IRRID): PRR1-10.2196/66050Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030JNCI Cancer Spectrum, 2021
- Breast cancer liver metastasis: current and future treatment approachesClinical & Experimental Metastasis, 2021
- National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important?The Annals of Thoracic Surgery, 2020
- Health care‐related time costs in patients with metastatic breast cancerCancer Medicine, 2020
- Digital interventions to facilitate patient‐provider communication in cancer care: A systematic reviewPsycho-Oncology, 2019
- The Support, Education, and Advocacy (SEA) Program of Care for Women With Metastatic Breast Cancer: A Nurse-Led Palliative Care Demonstration ProgramAmerican Journal of Hospice and Palliative Medicine®, 2019
- Metastatic and triple-negative breast cancer: challenges and treatment optionsDrug Delivery and Translational Research, 2018
- Estimation of the Number of Women Living with Metastatic Breast Cancer in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2017
- How to plan and perform a qualitative study using content analysisNursingPlus Open, 2016
- Statistical Intervals1991